JULIE MENSCHING: Open Payments
NPI 1295409282 · GENOA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,014 in 45 payments from 14 companies in 2025. Trend: 2023 $120 · 2024 $156 · 2025 $1,014
Food & beverage: $1,014
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $215 |
| Neurocrine BioSciences, Inc. | 6 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $103 |
| Alkermes, Inc. | 5 | $103 |
| Collegium Pharmaceutical, Inc. | 5 | $96 |
| Otsuka America Pharmaceutical, Inc. | 3 | $88 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
| Almatica Pharma LLC | 1 | $32 |
Products named: VRAYLAR, INGREZZA, REXULTI, CAPLYTA, Jornay PM, LYBALVI, Auvelity, ARISTADA.
Industry payments across IL — which companies pay providers there.
